MRF Home  
 

To support medical RESEARCH for finding effective treatments and eventually a cure for melanoma.

MRF Research Background

To EDUCATE patients and physicians about the prevention, diagnosis and treatment of melanoma.

MRF Education

To act as an ADVOCATE for the melanoma community to raise the awareness of this disease and the need for a cure.

MRF Advocacy
       
Melanoma Info
It's A Fact Information Sheet

Melanoma Questions?: "Ask A Nurse"

Just Diagnosed

MRF Detection & Prevention

Melanoma Related Links
1 2 3
 
Low prevalence of cdkn2a/arf mutations among early-onset cancers of breast, pancreas and malignant melanoma in poland.
By:  European Journal of Cancer Prevention Published On:  Wed, 20 Aug 2008 09:37:31 +0100
Oncogenic brafv600e inhibits bim expression to promote melanoma cell survival
By:  Pigment Cell Research Published On:  Wed, 20 Aug 2008 04:00:00 +0100
Phase ii trial of imatinib mesylate in patients with metastatic melanoma
By:  British Journal of Cancer AOP Published On:  Tue, 19 Aug 2008 04:00:00 +0100
Angiostatic activity of obtustatin as [alpha]1[beta]1 integrin inhibitor in experimental melanoma growth
By:  International Journal of Cancer Published On:  Tue, 19 Aug 2008 04:00:00 +0100
Clonal expansions of 6-thioguanine resistant t lymphocytes in the blood and tumor of melanoma patients
By:  Environmental and Molecular Mutagenesis Published On:  Tue, 19 Aug 2008 04:00:00 +0100
Fish melanoma gene linked to pigment pattern that attracts mates
By:  News-Medical News Feed Published On:  Tue, 19 Aug 2008 00:16:00 +0100
Prototype test for predicting clinical outcome for melanoma patients
By:  ScienceDaily Headlines Published On:  Mon, 18 Aug 2008 07:58:20 +0100
Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system
By:  World Journal of Surgical Oncology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Clinical problem solving: pathology: pathology quiz case
By:  Archives of Otolaryngology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Clinical problem solving: pathology: pathology quiz case: diagnosis
By:  Archives of Otolaryngology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Fish cancer gene linked to pigment pattern that attracts mates
By:  EurekAlert! - Biology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
By:  Glycobiology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Observation: the ringlike pattern in vulvar melanosis: a new dermoscopic clue for diagnosis
By:  Archives of Dermatology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Melanoma cells in voided urine cytology
By:  Cytopathology Published On:  Mon, 18 Aug 2008 04:00:00 +0100
Searching for the achilles' heel of melanoma cells: new treatment modalities
By:  Pigment Cell Research Published On:  Sun, 17 Aug 2008 04:00:00 +0100
Prototype test for predicting clinical outcome for melanoma patients - gene signature prognostication of rapid progression from stage iii to stage iv
By:  Genetics News From Medical News Today Published On:  Sat, 16 Aug 2008 07:00:00 +0100
The arful truth about melanoma susceptibility genes
By:  Pigment Cell Research Published On:  Fri, 15 Aug 2008 04:00:00 +0100
Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma
By:  British Journal of Haematology Published On:  Fri, 15 Aug 2008 04:00:00 +0100
Prototype test for predicting clinical outcome for melanoma patients
By:  EurekAlert! - Cancer Published On:  Fri, 15 Aug 2008 04:00:00 +0100
Moisturisers increased non-melanoma skin cancers in mice
By:  Health News from Medical News Today Published On:  Thu, 14 Aug 2008 18:00:00 +0100
1 2 3
Click here for more Melanoma News
Fear of Recurrence Teleconference - September 17, 2008

Annual Melanoma Symposium - Irvine CA, Oct. 11

Educational Programs

MRF Supporter: John Dane III, member of the 2008 US Olympic Sailing Team

MRF Press Room

Low prevalence of cdkn2a arf mutations among early-onset cancers of breast, pancreas and malignant melanoma in poland.

Oncogenic brafv600e inhibits bim expression to promote melanoma cell survival

Phase ii trial of imatinib mesylate in patients with metastatic melanoma

Angiostatic activity of obtustatin as [alpha]1[beta]1 integrin inhibitor in experimental melanoma growth

More...

© Copyright 2007, The Melanoma Research Foundation (MRF) |   Disclaimer |  Contact us |   Home